Soleus Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$83.8K Sell
10,000
-1,555,000
-99% -$11.2M ﹤0.01% 97
2026
Q2
$9.03M Sell
1,565,000
-285,000
-15% -$1.45M 0.31% 59
2026
Q1
$9.16M Buy
+1,850,000
New +$9M 0.37% 54

Other funds holding SOPH

Soleus Capital Management's SOPH Position: Q3 2026 in Review

Soleus Capital Management reduced its SOPHiA GENETICS (SOPH) stake by 99% in Q3 2026, selling an estimated $11.2M and leaving 10,000 shares worth $83.8K. The position accounts for ﹤0.01% of the portfolio, ranked #97.

Soleus Capital Management first reported a position in SOPH in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.16M in Q1 2026. 93 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

  • Soleus Capital Management held 10,000 shares of SOPHiA GENETICS worth $83.8K as of Q3 2026.
  • Soleus Capital Management sold 1,555,000 SOPHiA GENETICS shares in Q3 2026, an estimated $11.2M.
  • SOPHiA GENETICS made up ﹤0.01% of Soleus Capital Management's portfolio in Q3 2026, its #97 holding.
  • Soleus Capital Management first reported a position in SOPHiA GENETICS in Q1 2026 and has held it in 3 quarters since.
  • Soleus Capital Management's SOPHiA GENETICS position peaked at $9.16M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.